Story perspectives

Revolutionary mRNA Cancer Vaccine Shows 100% Efficacy in Trials

9/9/2025

Summary

Russian Scientists Innovate

Russian scientists created Enteromix, the first mRNA-based cancer vaccine, demonstrating 100% efficacy and safety in trials.
It specifically targets cancer cells, reducing harm to healthy tissue compared to traditional treatments.
Enteromix is personalized, using patients' unique tumor genetic profiles for optimal effectiveness.
Currently in early clinical use, it awaits final approval from the Russian Ministry of Health.
Developed by the National Medical Research Radiological Centre and Engelhardt Institute, it targets aggressive cancers.
Trials reported no serious side effects, indicating its potential as a safer treatment.
If approved, Enteromix could transform cancer therapy and be available free to Russian citizens.

Summary

FMBA Advances Cancer Vaccine

Russia's Federal Medical and Biological Agency (FMBA) reports a colorectal cancer vaccine shows 60-80% tumor shrinkage in preclinical trials.
The vaccine seeks regulatory approval, with human trials for advanced-stage patients projected for Q3 2026.
FMBA is also working on vaccines for glioblastoma and ocular melanoma, expanding cancer treatment efforts.
The vaccine targets existing cancers by stimulating the immune system, unlike preventive vaccines.
FMBA plans international collaborations to meet global scientific standards during testing.

1 of 2

Russian Scientists Innovate

Russian scientists created Enteromix, the first mRNA-based cancer vaccine, demonstrating 100% efficacy and safety in trials.
It specifically targets cancer cells, reducing harm to healthy tissue compared to traditional treatments.
Enteromix is personalized, using patients' unique tumor genetic profiles for optimal effectiveness.
Currently in early clinical use, it awaits final approval from the Russian Ministry of Health.
Developed by the National Medical Research Radiological Centre and Engelhardt Institute, it targets aggressive cancers.
Trials reported no serious side effects, indicating its potential as a safer treatment.
If approved, Enteromix could transform cancer therapy and be available free to Russian citizens.

1 / 2